GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,402.50p
   
  • Change Today:
    -32.50p
  • 52 Week High: 1,671.00
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,092.50m
  • Volume: 24,023,531
  • Market Cap: £57,397m
  • RiskGrade: 129

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
2.96% below the market average2.96% below the market average2.96% below the market average2.96% below the market average2.96% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
1yr Revenue Growth
1.41% below the market average1.41% below the market average1.41% below the market average1.41% below the market average1.41% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
23.33% above the market average23.33% above the market average23.33% above the market average23.33% above the market average23.33% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
1yr DPS Growth
6.97% above the market average6.97% above the market average6.97% above the market average6.97% above the market average6.97% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
11.27% below the market average11.27% below the market average11.27% below the market average11.27% below the market average11.27% below the market average
76.92% below the sector average76.92% below the sector average76.92% below the sector average76.92% below the sector average76.92% below the sector average
Price Book Ratio
73.23% below the market average73.23% below the market average73.23% below the market average73.23% below the market average73.23% below the market average
28.21% below the sector average28.21% below the sector average28.21% below the sector average28.21% below the sector average28.21% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
44.68% below the market average44.68% below the market average44.68% below the market average44.68% below the market average44.68% below the market average
4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average4.35% below the sector average
Price Chg 3m
57.82% below the market average57.82% below the market average57.82% below the market average57.82% below the market average57.82% below the market average
26.09% below the sector average26.09% below the sector average26.09% below the sector average26.09% below the sector average26.09% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
23.23% below the market average23.23% below the market average23.23% below the market average23.23% below the market average23.23% below the market average
Sector averageSector averageSector averageSector averageSector average
Momentum 20
86.45% below the market average86.45% below the market average86.45% below the market average86.45% below the market average86.45% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
17.27% above the market average17.27% above the market average17.27% above the market average17.27% above the market average17.27% above the market average
68.75% above the sector average68.75% above the sector average68.75% above the sector average68.75% above the sector average68.75% above the sector average
ROCE
68.49% above the market average68.49% above the market average68.49% above the market average68.49% above the market average68.49% above the market average
7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average7.69% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
90.75% above the market average90.75% above the market average90.75% above the market average90.75% above the market average90.75% above the market average
91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average
Forecast EPS
78.65% above the market average78.65% above the market average78.65% above the market average78.65% above the market average78.65% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
97.81% above the market average97.81% above the market average97.81% above the market average97.81% above the market average97.81% above the market average
93.75% above the sector average93.75% above the sector average93.75% above the sector average93.75% above the sector average93.75% above the sector average
Operating Profit Loss
97.93% above the market average97.93% above the market average97.93% above the market average97.93% above the market average97.93% above the market average
95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average95.65% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
97.20% above the market average97.20% above the market average97.20% above the market average97.20% above the market average97.20% above the market average
95.45% above the sector average95.45% above the sector average95.45% above the sector average95.45% above the sector average95.45% above the sector average
Cash
96.82% above the market average96.82% above the market average96.82% above the market average96.82% above the market average96.82% above the market average
95.56% above the sector average95.56% above the sector average95.56% above the sector average95.56% above the sector average95.56% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
74.94% above the market average74.94% above the market average74.94% above the market average74.94% above the market average74.94% above the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Buys 1y
99.33% above the market average99.33% above the market average99.33% above the market average99.33% above the market average99.33% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
94.31% below the market average94.31% below the market average94.31% below the market average94.31% below the market average94.31% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Brokers Percent Neutral
87.35% above the market average87.35% above the market average87.35% above the market average87.35% above the market average87.35% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,402.50p
Change Today -32.50p
% Change -2.26 %
52 Week High 1,671.00
52 Week Low 1,264.00
Volume 24,023,531
Shares Issued 4,092.50m
Market Cap £57,397m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.79% below the market average47.79% below the market average47.79% below the market average47.79% below the market average47.79% below the market average
39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average
Price Trend
7.48% above the market average7.48% above the market average7.48% above the market average7.48% above the market average7.48% above the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average
Income
73.31% above the market average73.31% above the market average73.31% above the market average73.31% above the market average73.31% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
33.33% below the market average33.33% below the market average33.33% below the market average33.33% below the market average33.33% below the market average
41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 20-Jun-2025

Time Volume / Share Price
15:51 0 @ 1,403.50p
15:51 1 @ 1,403.50p
15:51 0 @ 1,403.50p
15:43 1 @ 1,400.00p
15:51 1 @ 1,403.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page